These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8132152)

  • 1. Klebsiella oxytoca: resistance to aztreonam by overproduction of the chromosomally encoded beta-lactamase.
    Fournier B; Arlet G; Lagrange PH; Philippon A
    FEMS Microbiol Lett; 1994 Feb; 116(1):31-6. PubMed ID: 8132152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomal beta-lactamase of Klebsiella oxytoca, a new class A enzyme that hydrolyzes broad-spectrum beta-lactam antibiotics.
    Arakawa Y; Ohta M; Kido N; Mori M; Ito H; Komatsu T; Fujii Y; Kato N
    Antimicrob Agents Chemother; 1989 Jan; 33(1):63-70. PubMed ID: 2653216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and amino acid sequence of the OXY-2 group beta-lactamase of pI 5.7 isolated from aztreonam-resistant Klebsiella oxytoca strain HB60.
    Farzaneh S; Péduzzi J; Sofer L; Reynaud A; Barthélémy M; Labia R
    J Antimicrob Chemother; 1997 Dec; 40(6):789-95. PubMed ID: 9462429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Klebsiella oxytoca septicaemia isolates resistant to aztreonam and cefuroxime.
    Wu SW; Dornbusch K; Göransson E; Ransjö U; Kronvall G
    J Antimicrob Chemother; 1991 Sep; 28(3):389-97. PubMed ID: 1960120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of a new plasmid-encoded SHV-type beta-lactamase (SHV-2 variant) conferring high-level cefotaxime resistance upon Klebsiella pneumoniae.
    Podbielski A; Schönling J; Melzer B; Warnatz K; Leusch HG
    J Gen Microbiol; 1991 Mar; 137(3):569-78. PubMed ID: 2033379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal intensive care unit outbreak caused by a strain of Klebsiella oxytoca resistant to aztreonam due to overproduction of chromosomal beta-lactamase.
    Jeong SH; Kim WM; Chang CL; Kim JM; Lee K; Chong Y; Hwang HY; Baek YW; Chung HK; Woo IG; Ku JY
    J Hosp Infect; 2001 Aug; 48(4):281-8. PubMed ID: 11461129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Point mutation in the pribnow box, the molecular basis of beta-lactamase overproduction in Klebsiella oxytoca.
    Fournier B; Lu CY; Lagrange PH; Krishnamoorthy R; Philippon A
    Antimicrob Agents Chemother; 1995 Jun; 39(6):1365-8. PubMed ID: 7574532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended spectrum beta-lactamase from Klebsiella oxytoca, not belonging to the TEM or SHV family.
    Wu SW; Dornbusch K; Norgren M; Kronvall G
    J Antimicrob Chemother; 1992 Jul; 30(1):3-16. PubMed ID: 1429334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosomal beta-lactamase genes of Klebsiella oxytoca are divided into two main groups, blaOXY-1 and blaOXY-2.
    Fournier B; Roy PH; Lagrange PH; Philippon A
    Antimicrob Agents Chemother; 1996 Feb; 40(2):454-9. PubMed ID: 8834897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning and sequence of the gene encoding a cefotaxime-hydrolyzing class A beta-lactamase isolated from Escherichia coli.
    Ishii Y; Ohno A; Taguchi H; Imajo S; Ishiguro M; Matsuzawa H
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2269-75. PubMed ID: 8619581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro susceptibility of Klebsiella oxytoca strains to 13 beta-lactams in the presence and absence of beta-lactamase inhibitors.
    Fournier B; Lagrange PH; Philippon A
    J Antimicrob Chemother; 1996 May; 37(5):931-42. PubMed ID: 8737143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. beta-lactamase gene promoters of 71 clinical strains of Klebsiella oxytoca.
    Fournier B; Lagrange PH; Philippon A
    Antimicrob Agents Chemother; 1996 Feb; 40(2):460-3. PubMed ID: 8834898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of a unique ceftazidime-hydrolysing beta-lactamase, TEM-E2.
    Payne DJ; Marriott MS; Amyes SG
    J Med Microbiol; 1990 Jun; 32(2):131-4. PubMed ID: 2192063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strength and regulation of the different promoters for chromosomal beta-lactamases of Klebsiella oxytoca.
    Fournier B; Gravel A; Hooper DC; Roy PH
    Antimicrob Agents Chemother; 1999 Apr; 43(4):850-5. PubMed ID: 10103190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular aspects of high-level resistance to sulbactam-cefoperazone in Klebsiella oxytoca clinical isolates.
    Kimura K; Arakawa Y; Ohsuka S; Ito H; Suzuki K; Kurokawa H; Kato N; Ohta M
    Antimicrob Agents Chemother; 1996 Sep; 40(9):1988-94. PubMed ID: 8878568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Enzymatic resistance to cefotaxime in 56 strains of Klebsiella spp., Escherichia coli and Salmonella spp. at a Tunisian hospital (1984-1988)].
    Ben Hassen A; Fournier G; Kechrid A; Fendri C; Ben Redjeb S; Philippon A
    Pathol Biol (Paris); 1990 May; 38(5):464-9. PubMed ID: 2195457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outbreak of Klebsiella pneumoniae producing transferable AmpC-type beta-lactamase (ACC-1) originating from Hafnia alvei.
    Nadjar D; Rouveau M; Verdet C; Donay L; Herrmann J; Lagrange PH; Philippon A; Arlet G
    FEMS Microbiol Lett; 2000 Jun; 187(1):35-40. PubMed ID: 10828397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic characterization of resistance to extended-spectrum beta-lactams in Klebsiella oxytoca isolates recovered from patients with septicemia at hospitals in the Stockholm area.
    Wu SW; Dornbusch K; Kronvall G
    Antimicrob Agents Chemother; 1999 May; 43(5):1294-7. PubMed ID: 10223957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitor-resistant OXY-2-derived beta-lactamase produced by Klebsiella oxytoca.
    Sirot D; Labia R; Pouedras P; Chanal-Claris C; Cerceau C; Sirot J
    Antimicrob Agents Chemother; 1998 Sep; 42(9):2184-7. PubMed ID: 9736532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different promoters of SHV-2 and SHV-2a beta-lactamase lead to diverse levels of cefotaxime resistance in their bacterial producers.
    Podbielski A; Schönling J; Melzer B; Haase G
    J Gen Microbiol; 1991 Jul; 137(7):1667-75. PubMed ID: 1955859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.